This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Today is World Cancer Day. Each year, organizations and people from around the world unite on February 4th to raise awareness about cancer.
Download troubleshooting handbooks for IHC, Western blot and ELISA for FREE.
Troubleshooting guidesAccording to the American Cancer Society, cancer mortality had dropped 27% from 1991 to 2016. This decline is mostly attributed to decreases in smoking and advancements in early cancer detection and treatment.
Despite this reduction in cancer mortality, cancer remains as a major public health problem worldwide. In the US, cancer is the second leading cause of death. The American Cancer Society estimated 1,762,450 new cancer cases and 606,880 cancer deaths will happen in 2019 in the US. That’s approximately 4,800 new cases and 1,600 deaths each day.
Prostate, lung, and colorectal cancers are the most common cancers diagnosed in men, and these represent 42% of all cases in men. The most common cancers for women are breast, lung, and colorectal cancers, which represent 50% of all cases in women.
World Cancer Day empowers all of us across the world to show support and take action. Click below to find out more about cancer, the international campaign, research funding, and Boster antibodies & ELISA kits for your cancer research.
Get better results with Boster!
Boster takes great measures to ensure product quality and to provide our customers with comprehensive data upfront. Our antibodies are validated using WB, IHC, and flow cytometry against a panel of over 250 tissues and un-transfected cell lines to ensure high affinity and crystal-clear IHC stains. In addition, we also validate our antibodies in a quantitative fashion by testing them on known quantities of recombinant proteins so that you know what to expect (e.g. if there is 1ng, 2.5ng or 5ng of the target protein in the sample). Every product is covered by the Boster Quality Guarantee, click below to learn more.
Have questions? We're here to help.